Selected Papers Published
T. E. V. Rheenen, S. K. Davidson, F. Giorlando, E. Gliddon,
and O. M. Dean (2015). “Fostering early and mid-career
research in affective disorders”. Australian and New Zealand
Journal of Psychiatry.
O. Dandash, B. J. Harrison, R. Adapa, R. Gaillard,
F. Giorlando, S. J. Wood, P. C. Fletcher, and A. Fornito
(2014). “Selective Augmentation of Striatal Functional
Connectivity Following NMDA Receptor Antagonism:
Implications for Psychosis”. Neuropsychopharmacology.
F. Giorlando, J. Teister, S. Dodd, M. Udina, and M. Berk
(2013). “Hyponatraemia: An Audit of Aged Psychiatry
Patients Taking SSRIs and SNRIs”. Current Drug Safety 8.3,
pp. 175–180.
J. W. Moore, V. C. Cambridge, H. Morgan, F. Giorlando,
R. Adapa, and P. C. Fletcher (2013). “Time, action and
psychosis: Using subjective time to investigate the effects
of ketamine on sense of agency”. Neuropsychologia. Special
Issue: How Does the Brain Process Time? 51.2, pp. 377–384.
M. Berk, L. Berk, C. G. Davey, S. Moylan, F. Giorlando, A. B.
Singh, H. Kalra, and G. S. Malhi (2012). “Treatment of
bipolar depression”. Medical journal of Australia open 1.4,
pp. 32–35.
D. O. M. Dean, J. Data-Franco, F. Giorlando, and M. Berk
(2012). “Minocycline”. CNS Drugs 26.5, pp. 391–401.
S. Dodd, G. S. Malhi, J. Tiller, I. Schweitzer, I. Hickie,
J. P. Khoo, D. L. Basset, B. Lyndon, P. B. Mitchell, G.
Parker, P. B. Fitzgerald, M. Udina, A. Singh, S. Moylan,
F. Giorlando, C. Doughty, C. G. Davey, M. Theodoros,
and M. Berk (2012). “O-10 - Safety monitoring guidelines
for treatments for major depressive disorder”. European
Psychiatry. Abstracts of the 20th European Congress of
Psychiatry 27, Supplement 1, p. 1.
S. Moylan, F. Giorlando, T. Nordfj, and M. Berk (2012). “The
role of alprazolam for the treatment of panic disorder in
Australia”. Australian and New Zealand Journal of Psychiatry
46.3, pp. 212–224.
M. Berk, F. Kapczinski, A. Andreazza, O. Dean, F. Giorlando,
M. Maes, M. Ycel, C. Gama, S. Dodd, B. Dean, P. Magalh,
P. Amminger, P. McGorry, and G. Malhi (2011). “Pathways
underlying neuroprogression in bipolar disorder: Focus on
inflammation, oxidative stress and neurotrophic factors”.
Neuroscience & Biobehavioral Reviews 35.3, pp. 804–817.
J. T. Coull, H. Morgan, V. C. Cambridge, J. W. Moore,
F. Giorlando, R. Adapa, P. R. Corlett, and P. C. Fletcher
4/7